|
8.30 |
Registration, Networking & Breakfast |
|
9.00 |
Welcome & Opening Remarks
Brent Hoberman, Executive Chairman & Co-Founder, Founders Forum, Founders Factory, firstminute capital
Phil Newman, CEO & Founder, Longevity.Technology |
|
09:10 |
Consumer Diagnostics: Presentations and Q&A
This session will showcase a selection of the most exciting companies that are leveraging technology, data science, and AI to improve lifespan and healthspan on an individual and societal level. Learn how these technologies are helping improve healthspan and gain valuable insights from leading experts during a Q&A session.
Introducing Pioneering New Technologies and Business Models In At-Home and Rapid Diagnostics Alina Rui Su, Co-Founder & CEO, Generation Lab
The Convergence of AI and Epigenetics Matthew Dawson, CEO, TruDiagnostic
Digital Longevity and Population Scale Health Michael Geer, Co-Founder, Humanity
|
|
10:10 |
Longevity Biohacking: Showcase Highlighting the latest in biohacking advances to enhance metabolism and replace cellular function lost with the progression of age.
Through a series of dynamic presentations understand the latest advances in biohacking equipment and tracking effectiveness.
Erin Lee, Founder & CEO, Touchless Wellness Association Moderator: Tamsin Lewis, Founder & Medical Director, Wellgevity |
|
10:40 |
Refreshments & Networking |
|
11:05 |
Longevity Clinics: Presentations and Q&A Spotlighting the opportunities around physical and digital clinics for the professional diagnosis of health and ageing biomarkers in addition to clinical guidance on lifestyle, diet and therapeutic interventions to mitigate the progression of age. Followed by audience Q&A.
Developing a Location for Ongoing Client engagement Stephen Watson, Co-Founder & CEO, Founders Health
Building a Digital and AI Clinical Network William Kapp, Co-Founder & Chief Executive Officer, Fountain Life
|
|
11:45 |
The Future of Consumer Longevity Investment: Panel Discussion and Q&A Bringing together a distinguished panel of top investors to explore the latest trends, emerging opportunities, and transformative technologies within consumer longevity investments. These experts are at the forefront of funding breakthrough companies that are reshaping the way we think about ageing, wellness, and healthspan extension.
Amol Sarva, Managing Partner, LifeX Marc P. Bernegger, Founding Partner, Maximon |
|
12:10 |
Ageing Disease Prevention: Scientific Explainer and Panel Discussion In this session, we will explore the drivers of ageing with a scientific explainer, followed by an in-depth panel discussion on the latest clinical interventions aimed at controlling these drivers and preventing age-related diseases. The panel of leading experts will examine emerging therapies, cutting-edge research, and the potential for medical breakthroughs that could significantly delay or even prevent ageing diseases from manifesting.
Eric Morgen, Co-Founder & COO, BioAge Nils Regge, Co-Founder & General Partner, Apollo Health Ventures |
|
13:05 |
Lunch & Networking |
|
14:15 |
Targeted Age Reversal: Presentations and Q&A Exploring the latest therapeutic interventions that stop or reverse age-related damage in specific organs or for age-related diseases. Presentations on epigenetic and partial cellular reprogramming to restore cellular function followed by audience Q&A
Partial Cellular Reprogramming. Daniel Ives, CEO & Founder, Shift Bioscience
Epigenetic Reprogramming To Restore Cellular Function Sharon Rosenzweig-Lipson, Chief Scientific Officer, Life Biosciences |
|
15:15 |
Refreshments & Networking |
|
15:40 |
Systemic Age Reversal: Scientific Explainer and Showcase Introducing cutting edge therapeutic interventions that stop or reverse age-related damage throughout the whole body system. Including a scientific explainer and presentations from organisations at the forefront of the next frontier in regenerative medicine.
|
|
16:10 |
The Future of Biotech Longevity Investment: Panel Discussion and Q&A Join leading venture capitalists as they explore the rapidly evolving landscape of biotech longevity investment. Discover how VCs are identifying game-changing startups and the key factors driving investment decisions in this high-growth sector.
Gregory Bailey, Executive Chairman & Co-Founder, Juvenescence Laura Deming, CEO, Cradle, Co-Founder & Venture Partner, age1, Founder, Longevity Fund Will Harborne, Founding Partner & GP, LongGame Ventures |
|
16:35 |
Closing Remarks from Founders Forum & Longevity.Technology |
|
16:45 |
Close of Conference |
